-
Which ASX companies are resurrecting abandoned drugs? Part 1
15 Apr 2024 12:50 GMT
… development of the drug.
“Many small biotechs and pharma … for steroid pre-treatment
In some trials, clinical superiority … with annual sales of Abraxane peaking at US$ … drug receiving FDA approval for a human indication.
“NASDAQ-listed Tarsus Pharmaceuticals …
-
FDA Gives Fast Track Designation to LYT-200 in Advanced Head and Neck Cancers
12 Apr 2024 17:05 GMT
The FDA has granted fast track … either tislelizumab or nab-paclitaxel (Abraxane).
The primary end points in … primary, had a current illicit drug addiction, or had clinically significant … of another clinical trial within 3 weeks of study treatment, had radiation …
-
PROACTIVE Trial to Use Neoadjuvant Approach in Unresectable Pancreatic Adenocarcinoma
09 Apr 2024 16:54 GMT
… , clinical trial, especially for me, a gastrointestinal medical oncologist, … gemcitabine/nab-paclitaxel [Abraxane] for at least 2 … those patients in various trials, especially with borderline resectable … patients who got upfront treatment and did or did …
-
Ovarian cancer: four drug trials to watch
25 Mar 2024 15:22 GMT
… market for the seven major pharmaceutical markets (7MM: US, France … parent company of Clinical Trials Arena.
ADC associated AE … Gyneco-Oncology Unit at Rambam Medical Center in Israel. “ … and day after Abraxane treatment.
The global trial is estimated to …
-
Identifying Indications for Neoadjuvant Therapy in Cholangiocarcinoma
17 Apr 2024 17:18 GMT
… remain low. Recent randomized, controlled trials (RCTs) demonstrated improved survival … , cisplatin, and nab-paclitaxel (Abraxane) for patients with resectable, high … line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial …
-
Exploiting Nanotechnology for Drug Delivery: Advancing the Anti-Cancer Effects of Autophagy-Modulating Compounds in Traditional Chinese Medicine
12 Mar 2024 09:09 GMT
… -loaded albumin nanoparticles (Abraxane), liposomes loading Doxorubicin … for drug delivery in cancer therapy. Biotechnol Adv … towards precision medicine overcoming drug resistance. Drug Resist Updat … for Treatment of Breast Cancer. Pharmaceutics. 2022 …
-
Amplia Pharma gets US FDA nod to begin clinical trial of FAK inhibitor, narmafotinib in pancreatic cancer
19 Jan 2024 05:47 GMT
… an Australian pharmaceutical company, announced that the US FDA have cleared Amplia … clinical trial of narmafotinib, in combination with two chemotherapy drugs, gemcitabine and Abraxane … . Folfirinox is the preferred treatment for pancreatic patients in the …
-
ASX Health Stocks: Amplia gets FDA green light to commence trial; Recce study meets all primary endpoints
18 Jan 2024 02:47 GMT
… clinical trial
Recce’s clinical trial meets all primary endpoints
Recce Pharmaceuticals ( … trial of narmafotinib, in combination with two chemotherapy drugs, gemcitabine and Abraxane … treatment of pancreatic cancer.
“Clearance of the IND by the US FDA …
-
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Pancreatic Cancer
29 Feb 2024 12:48 GMT
… for phase 1 clinical trials in the US (NCT04640480 … drugs such as Abraxane® and Onivyde® are currently used as first-line treatments … costs, assistance for clinical trial design for clinical development … BioScience was founded by pharmaceutical R&D experts, …
-
Revolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcript
28 Feb 2024 15:54 GMT
… in a beaker in the biotechnology lab.
Second, we ended … combination drug cohorts to examine options for reaching into first-line treatment … the FDA about what to include in that final trial design … for those are, gem-ABRAXANE typically response rate in the …